US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Redeye: Paynova - 2.0

Redeye makes a positive revision of the Paynova investment case. Paynova is in the midst of a significant transformation of its business from the earlier model to now offering its pay-later technology to primarily payment platforms. Substantial new client traction gives us confidence in the business transformation and therefore raises our projections and valuation. In particular, we view the deals with PayPal (two actually) and Tradera as a real game-changer that confirms the attractiveness of Paynova's offering. Read more in our new research update: https://bit.ly/3faTMbL   Start

Redeye: Paynova - More growth ahead

As expected the new customer Skruvat.se was one of the biggest contributor to the revenue increase in Q2. However, the payment solution was only active one month in Q2, which means more revenue is expected in Q3. Panova's ambition is to go live in its first physical store in the first half of 2019.  Read more in our new research update: http://bit.ly/2QIgRaj  Start following companies at Redeye to receive the latest equity research within Life Science and Technology. This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se

Redeye: Paynova - Good risk/reward

The new customer Payzmart, has high ambitions in its goal to address 10-20% of the total Swedish market. However, Payzmart’s owner Unident has agreements with almost 85% of all dental clinics in the Nordics, which makes the financial goals realistic. Read our research update. Read more in our new Research Update by Tomas Otterbeck: https://goo.gl/9muVHB Start following companies at Redeye to receive the latest equity research within Life Science and Technology. This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se

There are no items matching the current filter
There are no more items matching the current filter
Back to top